Month: February 2014

Sphere Fluidics’ picodroplet technology was discussed in a TED video discussing how synthetic biology is exploring biological complexity. The speaker was Dr Sean Ward (a co-Founder and Chief Technology Officer of Synthace – a leading UK company focussing on Synthetic Biology). The video can be seen here.

Dr Frank F. Craig (CEO) and Dr Marian Rehak (R&D Director) will be attending BioEurope 2014 in Turin (Italy) during March 10th -12th. “We will also be exhibiting at the UK Pavilion and look forward to meeting other industry executives at the biopartnering event” said Dr Craig. “I am looking forward to discussing our new exciting instrumentation development program with other companies. Sphere Fluidics is planning to develop the world’s first integrated Monoclonality Assurance System. Monoclonality is essential for biopharmaceutical approval by all major, regulatory agencies. Our device provides significant operational cost-savings as well as up to 100-fold improvement in statistical accuracy” said Dr Rehak. Conference information can be found here.